The Myxobacterial Antibiotic Myxovalargin: Biosynthesis, Structural Revision, Total Synthesis, and Molecular Characterization of Ribosomal Inhibition is a research paper published in Journal of the American Chemical Society (2023). On theSindex it has a DataRank of 0.405. It has been cited 9 times, with 7 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.345
From this paper's citation signal
Citation Network Contribution
0.0598
From 5 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 7 citers.
Deutsche Forschungsgemeinschaft
Grant: WI3285/6-1
Bill and Melinda Gates Foundation
Grant: MULL17STB
Bill and Melinda Gates Foundation
Grant: OPP1024021
Bill and Melinda Gates Foundation
Grant: OPP1158806
iNEXT Consortium
Grant: 7033
National Research Foundation
Medical Research Council
Helmholtz-Gemeinschaft
Horizon 2020 Framework Programme
National Institute of Allergy and Infectious Diseases
FWCI
1.88
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals